Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies

Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies

Cardiovascular outcome trials (CVOT) showed that treatment with glucagon-like peptide-1 receptor agonists (GLP-1RA) is associated with significant cardiovascular benefits. However, CVOT are scarcely representative of everyday clinical practice, and real-world studies could provide clinicians with mo...

Full description

Bibliographic Details
Main Authors: Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Metabolites
Subjects:
type 2 diabetes
cardiovascular disease
renal disease
kidney
MACE
real-world evidence
Online Access:https://www.mdpi.com/2218-1989/12/2/183

Internet

https://www.mdpi.com/2218-1989/12/2/183

Similar Items